Rivaroxaban offers effective extended thromboprophylaxis than enoxaparin after THA

Lancet. 2008 Jul 5;372(9632):31-9. Epub 2008 Jun 24

Rivaroxaban is an adequate treatment for thromboprophylaxis after total knee arthroplasty

Lancet. 2009 May 16;373(9676):1673-80. Epub 2009 May 4

Similar extended VTE prophylaxis efficacy and safety between rivaroxaban and aspirin following TJA

N Engl J Med. 2018 Feb 22;378(8):699-707

COA-ACO2018: Comparison of VTE prophylaxis of aspirin vs. extended rivaroxaban after TKA/THA

Thromboprophylaxis with rivaroxaban versus enoxaparin in total knee and hip arthroplasty

Sci Rep. 2016 Mar 29;6:23726

No significant difference in DVT incidence between aspirin vs rivaroxaban in total knee arthroplasty

Rev Bras Ortop. 2017 Dec 6;53(1):22-27

AAOS2017: Assessing major wound complication rate of rivaroxaban, LMWH or placebo in THA

Rivaroxaban Superior to Enoxaparin in Non-Major Orthopaedic Surgery for Prevention of Major VTE

N Engl J Med. 2020 01-May;():. 10.1056/NEJMoa1913808

ISAKOS2017: Comparison of mechanical vs chemical thromboprophylaxis, including administration timing

TXA effective in reducing blood loss in mini-invasive TKA with postoperative rivaroxaban

J Arthroplasty. 2017 Mar;32(3):801-806

Aspirin or Rivaroxaban for Preventing Venous Thromboembolism after Total Knee Arthroplasty

Rev Bras Ortop (Sao Paulo). 2022 01-Oct;():. 10.1055/s-0041-1735941

100 mg Aspirin Twice Daily Non-Inferior to Once Daily 10 mg Rivaroxaban for Prevention of VTE in THA

Chin Med J (Engl). 2021 05-Jan;():. 10.1097/CM9.0000000000001305

ISAKOS 2015: 10 day Rivaroxaban reduces venous thromboembolism 3 months after TKA

New oral anticoagulants do not differ significantly in safety and efficacy from enoxaparin

BMJ. 2012 Jun 14;344:e3675. doi: 10.1136/bmj.e3675

Efficacy and safety of newer anticoagulants vs enoxaparin for thromboprophylaxis after TJA

J Arthroplasty. 2017 Feb;32(2):645-652

Novel oral anticoagulants are similar to conventional treatment for venous thromboembolism

BMJ. 2012 Nov 13;345:e7498. doi: 10.1136/bmj.e7498

Incidence of arterial thrombosis after administration of NOACs and LMWH in TKA and THA

Thromb Haemost. 2015 Jul 28;114(2):237-44

Routine thromboprophylaxis with anticoagulants unnecessary following nonmajor knee arthroscopy

J Thromb Thrombolysis. 2018 May;45(4):562-570

Anticoagulants not effective at preventing major VTE following knee arthroscopy

Int Orthop. 2019;43(10):2303-2308. 10.1007/s00264-018-4212-4

Major orthopedic surgery: Low-molecular-weight heparins vs other anticoagulants

Pharmacotherapy. 2012 Sep;32(9):799-808. doi: 10.1002/j.1875-9114.2012.01106.x. Epub 2012 Jun 28